» Articles » PMID: 18193081

N-myc Augments Death and Attenuates Protective Effects of Bcl-2 in Trophically Stressed Neuroblastoma Cells

Overview
Journal Oncogene
Date 2008 Jan 15
PMID 18193081
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

N-myc has proapoptotic functions, yet it acts as an oncogene in neuroblastoma. Thus, antiapoptotic mechanisms have to be operative in neuroblastoma cells that antagonize the proapoptotic effects of N-myc. We conditionally activated N-myc in SH-EP neuroblastoma cells subjected to the trophic stress of serum or nutrient deprivation while changing the expression of Bcl-2, survivin and FLIP(L), antiapoptotic molecules often overexpressed in poor prognosis neuroblastomas. Bcl-2 protected SH-EP cells from death during nutritional deprivation by activating energetically advantageous oxidative phosphorylation. N-myc overrode the metabolic protection provided by Bcl-2-induced oxidative phosphorylation by reestablishing the glycolytic phenotype and attenuated the antiapoptotic effect of Bcl-2 during metabolic stress. Survivin partially antagonized the growth suppressive function of N-myc in SH-EP neuroblastoma cells during serum deprivation whereas FLIP(L) did not. These findings advance our understanding of the functions of N-myc in neuroblastoma cells.

Citing Articles

MYC Drives mRNA Pseudouridylation to Mitigate Proliferation-Induced Cellular Stress during Cancer Development.

Ding J, Bansal M, Cao Y, Ye B, Mao R, Gupta A Cancer Res. 2024; 84(23):4031-4048.

PMID: 39240686 PMC: 11609627. DOI: 10.1158/0008-5472.CAN-24-1102.


MYC disrupts transcriptional and metabolic circadian oscillations in cancer and promotes enhanced biosynthesis.

Cazarin J, DeRollo R, Shahidan S, Burchett J, Mwangi D, Krishnaiah S PLoS Genet. 2023; 19(8):e1010904.

PMID: 37639465 PMC: 10491404. DOI: 10.1371/journal.pgen.1010904.


Deficiency of BAP1 inhibits neuroblastoma tumorigenesis through destabilization of MYCN.

Zhang X, Cong X, Jin X, Liu Y, Zhang T, Fan X Cell Death Dis. 2023; 14(8):504.

PMID: 37543638 PMC: 10404282. DOI: 10.1038/s41419-023-06030-5.


MYC disrupts transcriptional and metabolic circadian oscillations in cancer and promotes enhanced biosynthesis.

Cazarin J, DeRollo R, Shahidan S, Burchett J, Mwangi D, Krishnaiah S bioRxiv. 2023; .

PMID: 36711638 PMC: 9881876. DOI: 10.1101/2023.01.03.522637.


PPP2CA Is a Novel Therapeutic Target in Neuroblastoma Cells That Can Be Activated by the SET Inhibitor OP449.

Galiger C, Dahlhaus M, Vitek M, Debatin K, Beltinger C Front Oncol. 2022; 12:744984.

PMID: 35814385 PMC: 9258974. DOI: 10.3389/fonc.2022.744984.